Advagene Biopharma Co (ROCO:6709) Price-to-Operating-Cash-Flow : (As of Jun. 23, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co Price-to-Operating-Cash-Flow?

As of today (2024-06-23), Advagene Biopharma Co's share price is NT$23.60. Advagene Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.51. Hence, Advagene Biopharma Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Advagene Biopharma Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:6709's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.48
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Advagene Biopharma Co's Cash Flow from Operations per share for the six months ended in Jun. 2023 was NT$-0.79. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.51.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -30.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -16.80% per year.

During the past 8 years, Advagene Biopharma Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.40% per year. The lowest was -40.50% per year. And the median was -7.50% per year.

Advagene Biopharma Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Advagene Biopharma Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co Price-to-Operating-Cash-Flow Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Advagene Biopharma Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Advagene Biopharma Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's Price-to-Operating-Cash-Flow falls into.

Advagene Biopharma Co Price-to-Operating-Cash-Flow Calculation

Advagene Biopharma Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	23.60	/	-1.508
	=

Advagene Biopharma Co's Share Price of today is NT$23.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advagene Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.51.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Advagene Biopharma Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines